Your browser doesn't support javascript.
loading
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
Ponatshego, Ponego Lloyd; Lawrence, David Stephen; Youssouf, Nabila; Molloy, Sile F; Alufandika, Melanie; Bango, Funeka; Boulware, David R; Chawinga, Chimwemwe; Dziwani, Eltas; Gondwe, Ebbie; Hlupeni, Admire; Hosseinipour, Mina C; Kanyama, Cecilia; Meya, David B; Mosepele, Mosepele; Muthoga, Charles; Muzoora, Conrad K; Mwandumba, Henry; Ndhlovu, Chiratidzo E; Rajasingham, Radha; Sayed, Sumaya; Shamu, Shepherd; Tsholo, Katlego; Tugume, Lillian; Williams, Darlisha; Maheswaran, Hendramoorthy; Shiri, Tinevimbo; Boyer-Chammard, Timothée; Loyse, Angela; Chen, Tao; Wang, Duolao; Lortholary, Olivier; Lalloo, David G; Meintjes, Graeme; Jaffar, Shabbar; Harrison, Thomas S; Jarvis, Joseph N; Niessen, Louis Wilhelmus.
Afiliação
  • Ponatshego PL; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Lawrence DS; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Youssouf N; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Molloy SF; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Alufandika M; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Bango F; Research Centre for Infection and Immunity, St. George's University of London, London, UK.
  • Boulware DR; Malawi-Liverpool-Wellcome Trust Clinical Research Centre, Blantyre, Malawi.
  • Chawinga C; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Dziwani E; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Gondwe E; Department of Medicine, University of Minnesota, Minnesota, USA.
  • Hlupeni A; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
  • Hosseinipour MC; Malawi-Liverpool-Wellcome Trust Clinical Research Centre, Blantyre, Malawi.
  • Kanyama C; Malawi-Liverpool-Wellcome Trust Clinical Research Centre, Blantyre, Malawi.
  • Meya DB; Department of Medicine, University of Zimbabwe, Harare, Zimbabwe.
  • Mosepele M; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
  • Muthoga C; Lilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
  • Muzoora CK; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Mwandumba H; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Ndhlovu CE; Department of Internal Medicine, University of Botswana, Gaborone, Botswana.
  • Rajasingham R; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Sayed S; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Shamu S; Malawi-Liverpool-Wellcome Trust Clinical Research Centre, Blantyre, Malawi.
  • Tsholo K; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Tugume L; Department of Medicine, University of Zimbabwe, Harare, Zimbabwe.
  • Williams D; Department of Medicine, University of Minnesota, Minnesota, USA.
  • Maheswaran H; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Shiri T; Department of Medicine, University of Zimbabwe, Harare, Zimbabwe.
  • Boyer-Chammard T; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Loyse A; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Chen T; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Wang D; Department of Medicine, University of Minnesota, Minnesota, USA.
  • Lortholary O; Malawi-Liverpool-Wellcome Trust Clinical Research Centre, Blantyre, Malawi.
  • Lalloo DG; Population Evidence and Technologies, University of Warwick, Coventry, UK.
  • Meintjes G; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Jaffar S; Molecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
  • Harrison TS; Research Centre for Infection and Immunity, St. George's University of London, London, UK.
  • Jarvis JN; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Niessen LW; Department of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
BMJ Open ; 9(4): e026288, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30940760
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anfotericina B / Meningite Criptocócica / Custos de Medicamentos / Gastos em Saúde Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anfotericina B / Meningite Criptocócica / Custos de Medicamentos / Gastos em Saúde Idioma: En Ano de publicação: 2019 Tipo de documento: Article